Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

399 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Successful treatment of Kaposi's sarcoma in a renal allograft recipient.
Marsman WA, Van Gelder T, Mulder AH, Ijzermans JN, Zietse R, Weimar W. Marsman WA, et al. Nephrol Dial Transplant. 1995;10(6):900-1. Nephrol Dial Transplant. 1995. PMID: 7566628 No abstract available.
A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation.
van Gelder T, Zietse R, Mulder AH, Yzermans JN, Hesse CJ, Vaessen LM, Weimar W. van Gelder T, et al. Transplantation. 1995 Aug 15;60(3):248-52. doi: 10.1097/00007890-199508000-00007. Transplantation. 1995. PMID: 7645037 Clinical Trial.
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation.
van Gelder T, Balk AH, Jonkman FA, Zietse R, Zondervan P, Hesse CJ, Vaessen LM, Mochtar B, Weimar W. van Gelder T, et al. Transplantation. 1996 Jul 15;62(1):51-5. doi: 10.1097/00007890-199607150-00011. Transplantation. 1996. PMID: 8693545 Clinical Trial.
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans.
van Gelder T, Baan CC, Balk AH, Knoop CJ, Holweg CT, van der Meer P, Mochtar B, Zondervan PE, Niesters HG, Weimar W. van Gelder T, et al. Transplantation. 1998 Feb 15;65(3):405-10. doi: 10.1097/00007890-199802150-00020. Transplantation. 1998. PMID: 9484761 Clinical Trial.
399 results
Jump to page
Feedback